Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.9M Sell
1,567,122
-12,921
-0.8% -$228K 0.04% 335
2026
Q1
$27.2M Buy
1,580,043
+44,815
+3% +$798K 0.05% 335
2025
Q4
$26.5M Buy
1,535,228
+41,501
+3% +$678K 0.04% 336
2025
Q3
$24.2M Buy
1,493,727
+61,250
+4% +$1.25M 0.04% 337
2025
Q2
$30M Buy
1,432,477
+91,744
+7% +$2.09M 0.06% 284
2025
Q1
$32.2M Buy
1,340,733
+186,032
+16% +$4.12M 0.08% 265
2024
Q4
$24.7M Buy
1,154,701
+1,063,043
+1,160% +$24.1M 0.06% 287
2024
Q3
$2.12M Buy
91,658
+75,018
+451% +$1.55M 0.01% 540
2024
Q2
$303K Buy
+16,640
New +$322K ﹤0.01% 878
2024
Q1
Sell
-350,826
Closed -$7.55M 984
2023
Q4
$7.55M Sell
350,826
-705,651
-67% -$14.1M 0.03% 476
2023
Q3
$21.2M Buy
+1,056,477
New +$24.5M 0.09% 291

Other funds holding KVUE

Aviva's KVUE Position: Q2 2026 in Review

Aviva reduced its Kenvue (KVUE) stake by 0.82% in Q2 2026, selling an estimated $228K and leaving 1,567,122 shares worth $29.9M. The position accounts for 0.04% of the portfolio, ranked #335.

Aviva first reported a position in KVUE in Q3 2023 and has held it in 11 quarters since. The position peaked at $32.2M in Q1 2025. 1,002 funds tracked by Wall St. Rank hold KVUE as of Q2 2026.

  • Aviva held 1,567,122 shares of Kenvue worth $29.9M as of Q2 2026.
  • Aviva sold 12,921 Kenvue shares in Q2 2026, an estimated $228K.
  • Kenvue made up 0.04% of Aviva's portfolio in Q2 2026, its #335 holding.
  • Aviva first reported a position in Kenvue in Q3 2023 and has held it in 11 quarters since.
  • Aviva's Kenvue position peaked at $32.2M in Q1 2025.
  • 1,002 funds tracked by Wall St. Rank held Kenvue as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.